
    
      Part 1 of study(Phase 2) is planned to have 120 patients and anticipated completion on July
      2019. Recruitment completed.

      Part 2 of study(Phase 3) is planned to have 350 patients and anticipated completion on Dec
      2022. Not yet recruiting.
    
  